what are the long term effects of glp-1 Adverse Receptor Agonists Exploring the Side Effects of

SNAC shields semaglutide, the active ingredient in Rybelsus and Wegovy pill from being broken down in the stomach

Eli Lilly priced FOUNDAYO comparably to the WEGOVY pill, with self-pay access starting at $149/month for the lowest dose, eligible commercial insurance patients paying as low as $25/month with savings cards, and Medicare Part D patients expected to access it for $50/month beginning July 1, 2026

For a 250-pound person, that is over 60 pounds

Like other GLP-1 therapies, side effects matter

Advances in solid-phase peptide synthesis, recombinant expression, and purification technologies have substantially reduced these barriers, enabling large-scale production of complex peptides with acceptable margins

Return to the Longevity Medicine Guide